Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 1996, Vol. 1 ›› Issue (2): 112-113.

Previous Articles     Next Articles

The Clinical Use of Anticoagulant in.Diabetic Nephropathy (DN) of NIDDM

Wang Zhanjian, Pan Shufang1, Li Ying, Gu Lianfan   

  1. Department of Internal Medicine,Third Hospital, Hebei Medical University, Shijiazhuang 050051
  • Received:1996-10-21 Revised:1996-11-06 Published:2020-12-03

Abstract: Aim The study was aimed to investigate the nechanism of anticoagulant in reducing urinary albumin excreling rate (UAER). Methods Fifty-eight patients at their microalbuminuria stage of NIDDM (H stage of DN) were treated by anticoagulant (acid acetylsalicylic enter-solubilis and dipyridamole). The relationship between UAER and hypercoagulability was ob-served before and after treatment. Results It was found that anticoagulant significantly reduced UAER. With improvement of hypercoagulability, UAER was decreased remarkably (P<0.05). Conclusion Dipyridamole and acid acetylsalicylic entersolubilis are easy,effi-cient and safe drugs for redycing UAER of DN.

Key words: Anticagulant, Diabetic nephropathy

CLC Number: